U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1721 - 1730 of 2111 results

Status:
Possibly Marketed Outside US
Source:
NCT04560283: Phase 4 Interventional Completed Vagina; Anomaly
(2016)
Source URL:
First approved in 1990
Source:
Flor-Opal Sustained-Release Fluoride by Ultradent Products, Inc
Source URL:

Class:
POLYMER

structurally diverse
Status:
US Approved Rx (2015)
Source:
BLA125510
(2015)
Source URL:
First approved in 2015
Source:
BLA125510
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2015)
Source:
BLA125510
(2015)
Source URL:
First approved in 2015
Source:
BLA125510
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2015)
Source:
BLA125510
(2015)
Source URL:
First approved in 2015
Source:
BLA125510
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2010)
Source:
BLA125324
(2010)
Source URL:
First approved in 2010
Source:
BLA125324
Source URL:

Class:
STRUCTURALLY DIVERSE

Showing 1721 - 1730 of 2111 results